Nuveen’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
– Sell
-16,400
Closed -$5K – 3215
2019
Q4
$5K Buy
+16,400
New +$4.51M ﹤0.01% 3190

Other funds holding ELV

Nuveen's ELV Position: Q2 2026 in Review

Nuveen increased its Elevance Health (ELV) stake by 1.5% in Q2 2026, buying an estimated $10.8M and bringing the position to 1,989,863 shares worth $770M. The position accounts for 0.18% of the portfolio, ranked #99.

Nuveen first reported a position in ELV in Q2 2013 and has held it in 53 quarters since. The position peaked at $1.61B in Q4 2022. 1,611 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Nuveen held 1,989,863 shares of Elevance Health worth $770M as of Q2 2026.
  • Nuveen bought 29,158 Elevance Health shares in Q2 2026, an estimated $10.8M.
  • Elevance Health made up 0.18% of Nuveen's portfolio in Q2 2026, its #99 holding.
  • Nuveen first reported a position in Elevance Health in Q2 2013 and has held it in 53 quarters since.
  • Nuveen's Elevance Health position peaked at $1.61B in Q4 2022.
  • 1,611 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.